{"id":966,"date":"2026-05-21T08:24:26","date_gmt":"2026-05-21T08:24:26","guid":{"rendered":"https:\/\/isbm-blow-molding.com\/?p=966"},"modified":"2026-05-21T08:24:26","modified_gmt":"2026-05-21T08:24:26","slug":"isbm-medical-device-bottle-production-korean-guide","status":"publish","type":"post","link":"https:\/\/isbm-blow-molding.com\/ko\/isbm-medical-device-bottle-production-korean-guide\/","title":{"rendered":"ISBM Medical Device Bottle Production: Korean Regulatory Guide 2026"},"content":{"rendered":"<div style=\"margin: 0; padding: 20px; font-family: 'Helvetica Neue',Helvetica,Arial,sans-serif; color: #1f2937; line-height: 1.78; background: #fff;\">\n<p><!-- HERO: clean medical blue --><\/p>\n<header style=\"position: relative; min-height: min(580px,86vh); display: flex; align-items: center; padding: clamp(40px,6vw,80px) clamp(18px,5vw,56px); background: #020c1a; background-image: linear-gradient(150deg,rgba(2,8,22,0.98) 0%,rgba(4,22,54,0.94) 58%,rgba(3,105,161,0.34) 100%),url('https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/ISBM-2.webp'); background-size: cover; background-position: center;\">\n<div style=\"max-width: 680px;\"><span style=\"display: inline-block; font-size: 10px; font-weight: bold; letter-spacing: 2.5px; text-transform: uppercase; color: #7dd3fc; border: 1px solid rgba(125,211,252,0.35); padding: 4px 12px; border-radius: 3px; margin-bottom: 18px;\">Application of ISBM \u00b7 Medical Device Packaging \u00b7 Korean ISBM 2026<\/span><\/p>\n<h1 style=\"font-size: clamp(24px,4.2vw,40px); font-weight: 900; color: #fff; line-height: 1.18; margin: 0 0 20px; letter-spacing: -0.5px;\">ISBM Medical Device Bottle<br \/>\nProduction: Korean Regulatory Guide<\/h1>\n<p style=\"font-size: clamp(14px,1.9vw,17px); color: #e0f2fe; line-height: 1.7; margin: 0 0 28px; max-width: 560px;\">Korean medical device packaging is the highest-compliance ISBM application \u2014 where every bottle must be biocompatibility-tested, sterilisation-validated, dimensionally qualified to GMP IQ\/OQ\/PQ standards, and manufactured in a documented clean environment. Korean ISBM producers who enter this market correctly build a supplier qualification that Korean medical device companies renew for 10\u201315 years. Those who enter without understanding the regulatory framework produce bottles that fail the first KFDA supplier audit.<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 8px;\"><span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #e0f2fe; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">KFDA Class I\u2013IV Regulatory Framework<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #e0f2fe; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">ISO 10993 Biocompatibility<\/span><br \/>\n<span style=\"background: rgba(255,255,255,0.08); border: 1px solid rgba(255,255,255,0.18); color: #e0f2fe; font-size: 11.5px; font-weight: 600; padding: 5px 14px; border-radius: 20px;\">GMP IQ \/ OQ \/ PQ Validation<\/span><\/div>\n<p style=\"font-size: 11px; color: #38bdf8; margin: 22px 0 0;\">\uc5d0\ubc84\ud30c\uc6cc \ud55c\uad6d \uc5d4\uc9c0\ub2c8\uc5b4\ub9c1 \ub370\uc2a4\ud06c \u00b7 \uc548\uc0b0\uc2dc \u00b7 2026\ub144 5\uc6d4<\/p>\n<\/div>\n<\/header>\n<p>&nbsp;<\/p>\n<p><!-- KFDA CLASSIFICATION REFERENCE --><\/p>\n<div style=\"background: #f0f9ff; border: 1px solid #bae6fd; border-radius: 8px; padding: 20px 24px; margin: 44px 0 0;\">\n<p style=\"font-size: 10.5px; font-weight: 800; letter-spacing: 2px; text-transform: uppercase; color: #075985; margin: 0 0 14px;\">Korean KFDA Medical Device Classification \u2014 Packaging Impact Summary<\/p>\n<div style=\"overflow-x: auto;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13px; min-width: 520px;\">\n<thead>\n<tr style=\"background: #075985;\">\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">KFDA Class<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">Korean Approval Path<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">Packaging Requirement<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">Korean ISBM Application<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Class I<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">\uc2e0\uace0 (Notification)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">Basic material traceability + dimensions<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">Sample cups, low-risk specimen containers<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Class II<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">\uc778\uc99d (Certification)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">ISO 10993 biocompatibility + GMP documentation<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">IVD reagent bottles, diagnostic kits, wash bottles<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600; color: #0369a1;\">Class III<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">\ud5c8\uac00 (KFDA Approval)<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600; color: #0369a1;\">Full GMP validation + extractables\/leachables<\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #bae6fd;\">Drug delivery system containers, sterile device packaging<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 8px 12px; font-weight: 600; color: #0369a1;\">Class IV<\/td>\n<td style=\"padding: 8px 12px;\">\ud5c8\uac00 (KFDA Approval)<\/td>\n<td style=\"padding: 8px 12px; font-weight: 600; color: #0369a1;\">Full GMP + clinical data + sterilisation validation<\/td>\n<td style=\"padding: 8px 12px;\">Implant component containers, life-sustaining device packaging<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n<p><!-- TOC --><\/p>\n<nav style=\"margin: 32px 0 0; background: #f9fafb; border: 1px solid #e5e7eb; border-radius: 8px; padding: 20px 22px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; text-transform: uppercase; letter-spacing: 1.5px; color: #374151; margin: 0 0 12px;\">Contents<\/p>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit,minmax(min(100%,260px),1fr)); gap: 4px 20px;\"><a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s1\">1. Korean Medical Device Packaging Market and ISBM&#8217;s Role<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s2\">2. KFDA Medical Device Registration Framework<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s3\">3. Material Selection: PET, PETG, and PP for Medical Containers<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s4\">4. ISO 10993 Biocompatibility Evaluation Protocol<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s5\">5. Sterilisation Method Compatibility<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s6\">6. Extractables and Leachables: KFDA Expectations<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s7\">7. Cleanroom Production Standards for Korean ISBM<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#s8\">8. GMP Validation: IQ, OQ, and PQ for Korean ISBM Lines<\/a><br \/>\n<a style=\"color: #0369a1; text-decoration: none; font-size: 14px; padding: 3px 0; display: block;\" href=\"#faq\">FAQ<\/a><\/div>\n<\/nav>\n<p><!-- S1 --><\/p>\n<section id=\"s1\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #0369a1;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">1. Korean Medical Device Packaging Market and ISBM&#8217;s Role<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/Injection-Stretch-Blow-Molding-HGY150-V4-EV.webp\" alt=\"Korean Ever-Power ISBM Machine HGY150-V4-EV all-electric servo for Korean medical device bottle production \u2014 EV servo \u00b10.05s blow dwell precision, \u00b10.3\u00b0C conditioning temperature uniformity, and cycle-by-cycle GMP process data logging for KFDA Class II and III medical device packaging validation documentation\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Korean Ever-Power HGY150-V4-EV all-electric ISBM platform for Korean medical device packaging \u2014 the EV servo&#8217;s \u00b10.3\u00b0C conditioning temperature precision, \u00b10.05s blow dwell timing, and cycle-by-cycle process logging address the three KFDA GMP requirements that distinguish medical device ISBM from pharmaceutical ISBM: validated process parameter ranges, electronic process records with audit trails, and production data retention for the full device registration period (minimum 3 years from manufacture date under Korean KFDA \uc758\ub8cc\uae30\uae30\uc758 \uc81c\uc870 \ubc0f \ud488\uc9c8\uad00\ub9ac \uae30\uc900).<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korea&#8217;s medical device industry \u2014 ranked globally among the top 10 by value and expanding at 8.5% annually to KRW 12.4 trillion in 2025 \u2014 requires a substantial volume of precision plastic containers for in vitro diagnostics (IVD), reagent storage, sample collection, and pharmaceutical delivery device packaging. Korean ISBM bottles serve this market because ISBM&#8217;s one-step process produces containers with the dimensional precision (\u00b10.04mm neck OD), optical clarity (haze \u22642.5% for visual fill-level confirmation), and structural integrity (wall thickness CV% \u22648%) that Korean medical device companies require as the primary container for reagents, wash solutions, calibration fluids, and diagnostic kit components.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean ISBM competes favourably against glass and IBM (injection blow moulding) for Korean medical device containers in three specific size and geometry categories. First, 30ml\u2013500ml bottles with narrow to medium necks (13\u201338mm) where ISBM&#8217;s superior wall uniformity and optical clarity exceed IBM&#8217;s capability without the weight and breakage risk of glass. Second, multi-cavity precision production (2\u20134 cavities) of identical bottles for kit components where cavity-to-cavity dimensional variation must meet \u2264\u00b10.04mm neck OD \u2014 a specification that ISBM satisfies through one-step preform-to-bottle control. Third, transparent reagent bottles where fill-level visibility is a safety function rather than an aesthetic preference \u2014 a requirement that eliminates opaque options entirely and demands the Korean ISBM haze performance (\u22642.5%) that confirms reagent level from 0.5 metres distance.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">The key ISBM advantage for Korean medical device applications is the same as for Korean pharmaceutical: cycle-by-cycle process traceability. Korean KFDA medical device GMP (\uc758\ub8cc\uae30\uae30\uc758 \uc81c\uc870 \ubc0f \ud488\uc9c8\uad00\ub9ac \uae30\uc900, equivalent to ISO 13485) requires that primary container manufacturing process conditions are documented for each production lot. The Korean EV servo ISBM platforms in the <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/ko\/%ec%a0%9c%ed%92%88+%ec%b9%b4%ed%85%8c%ea%b3%a0%eb%a6%ac\/4-station-isbm-machine\/\">Korean Ever-Power 4-Station ISBM Machine Range<\/a> generate this data automatically \u2014 making the GMP documentation burden for Korean medical device packaging a data management task rather than a manual inspection task.<\/p>\n<\/section>\n<p><!-- S2 --><\/p>\n<section id=\"s2\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">2. KFDA Medical Device Registration Framework: What Korean ISBM Packaging Producers Need to Know<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean KFDA classifies medical devices under the \uc758\ub8cc\uae30\uae30\ubc95 (Medical Device Act) into four classes based on risk level. The classification determines the approval pathway and, critically for packaging producers, the depth of manufacturing documentation and validation required. Korean ISBM packaging producers must understand which class their customer&#8217;s device falls under \u2014 because the packaging manufacturer&#8217;s GMP obligations are driven by the device class, not by the packaging manufacturer&#8217;s own classification.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean Class I medical devices (\uc2e0\uace0\ud488\ubaa9) cover low-risk devices and accessories including general sample collection vessels, Class I specimen cups, and packaging for non-sterile non-contact accessories. Korean ISBM containers for Class I applications require only basic material identification (resin grade, colour masterbatch lot), dimensional records (neck OD, bottle height, weight), and food contact positive list confirmation. Korean ISBM producers already meeting Korean food contact packaging standards can supply Class I medical device containers with minimal additional documentation investment.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean Class II medical devices (\uc778\uc99d\ud488\ubaa9) cover moderate-risk IVD reagent containers, diagnostic kit components, wash solution bottles, and clinical specimen storage containers. Korean ISBM packaging for Class II requires ISO 10993 biocompatibility evaluation (cytotoxicity minimum), material traceability to specific lot and grade, dimensional qualification certificate from each cavity, and GMP batch record retention. The Korean notified body (\uc778\uc99d\uae30\uad00) that certifies the device manufacturer reviews the packaging manufacturer&#8217;s quality documentation as part of the device certification audit \u2014 making packaging GMP documentation a direct prerequisite for the medical device customer&#8217;s KFDA certification.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korean Class III and IV medical devices (\ud5c8\uac00\ud488\ubaa9) covering drug delivery systems, sterile device contact surfaces, and life-sustaining device packaging require the most complete Korean ISBM manufacturing validation: full ISO 10993 biocompatibility series (typically ISO 10993-5 cytotoxicity, ISO 10993-10 sensitisation, ISO 10993-12 sample preparation), extractables and leachables (E&amp;L) study, GMP IQ\/OQ\/PQ validation, sterilisation validation (if the container is sterilised after filling), and KFDA primary container registration under the device&#8217;s \ud5c8\uac00 (approval) dossier. Korean ISBM producers entering Class III\/IV supply must plan a 6\u201312 month qualification timeline and KRW 25\u201355M validation investment before first commercial delivery.<\/p>\n<\/section>\n<p><!-- S3 --><\/p>\n<section id=\"s3\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">3. Material Selection: PET, PETG, and PP for Korean Medical Device Containers<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/bottle-7.webp\" alt=\"Korean ISBM medical device PET bottles \u2014 clear PET Class II IVD reagent bottles with neck OD \u00b10.04mm tolerance for Korean diagnostics kit secondary packaging, showing crystal clarity for fill-level visual confirmation and consistent neck thread profile for closure torque compatibility\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Korean ISBM medical device PET bottles \u2014 Class II IVD reagent storage in crystal PET (haze \u22642.0%) with \u00b10.04mm neck OD qualification. The Korean diagnostics industry&#8217;s standard neck finish is GPI 24\/415 for 15\u2013100ml reagent bottles and GPI 28\/415 for 100\u2013500ml \u2014 enabling standardised Korean snap-cap and screw-cap closure qualification across multiple Korean IVD manufacturers&#8217; kit component bottles from a single qualified Korean ISBM supplier.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Material selection for Korean ISBM medical device containers is driven by three factors: chemical compatibility with the specific reagent or device content, sterilisation method compatibility, and regulatory compliance. Unlike Korean K-Beauty applications where PETG is the preferred material for aesthetics, Korean medical device applications require deliberate material analysis before selection \u2014 PETG, PET, and PP each have specific strengths and limitations that determine their suitability for different device categories.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><strong>PET for Korean medical devices:<\/strong> PET (polyethylene terephthalate) is the most widely used Korean ISBM material for Class I and II medical device containers. Its advantages are low extractables at ambient storage temperatures (well-characterised by ISO 10993-17 for risk assessment), broad chemical compatibility covering aqueous solutions, acidic buffers (pH 3\u20139), and saline solutions that represent the majority of Korean IVD reagent matrices, and strong compliance history in Korean KFDA submissions. Its limitations: PET deforms above 65\u201370\u00b0C (relevant for gamma sterilisation heat loads \u2014 usually not a concern since PET is sterilised at room temperature by gamma or EO), PET absorbs UV radiation below 340nm (relevant for UV-sensitive reagents \u2014 specify UV-stabilised PET grades for photosensitive diagnostics formulations), and PET should not be used for reagents with organic solvent content above 10% (stress cracking risk).<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><strong>PETG for Korean medical devices:<\/strong> PETG (polyethylene terephthalate glycol) is preferred for Korean Class II diagnostic kit components where crystal clarity (haze \u22641.5%) is required for colorimetric assay visual interpretation, and for Korean IVD containers requiring snap-break or score-line features that PET&#8217;s higher rigidity makes more difficult to achieve. PETG&#8217;s lower chemical resistance to certain organic solvents (ethanol above 40%, acetone, MEK) limits its use for Korean laboratory wash solutions and solvent-containing reagents \u2014 verify compatibility before specifying PETG for any Korean medical device reagent above 30% organic solvent concentration.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\"><strong>PP for Korean medical devices:<\/strong> Polypropylene is the correct material choice for Korean medical device containers that must withstand steam autoclaving (121\u00b0C for 20 minutes) \u2014 PET and PETG cannot survive autoclave temperatures. PP ISBM for Korean autoclave-compatible medical device containers requires the PP hot-fill ISBM capability (conditioning 120\u2013145\u00b0C, heated mould base inserts) \u2014 a more technically demanding and less widely available process than PET ISBM. Korean ISBM producers quoting PP medical device containers should verify their machine&#8217;s conditioning station maximum temperature before accepting the contract. The optical clarity requirements that PETG enables for colorimetric applications are addressed in the full guide to <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/ko\/how-to-improve-transparency-isbm-injection-stretch-blow-molding\/\">Korean ISBM transparency improvement<\/a>.<\/p>\n<\/section>\n<p><!-- S4 --><\/p>\n<section id=\"s4\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">4. ISO 10993 Biocompatibility Evaluation: What Korean ISBM Producers Must Provide<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">ISO 10993-1:2018 (Biological evaluation of medical devices \u2014 Part 1: Evaluation and testing within a risk management process) is the international standard for biocompatibility assessment that Korean KFDA references for all Korean medical device primary packaging. ISO 10993 does not prescribe a fixed test battery \u2014 it specifies a risk-based evaluation approach that selects tests according to the device&#8217;s nature of contact with the human body (surface contact, breached surface, blood contact) and duration (limited, prolonged, permanent).<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">For Korean ISBM reagent bottles (Class II IVD, indirect contact with patient \u2014 reagent contacts the instrument, not the patient): the biocompatibility evaluation is typically limited to ISO 10993-5 (cytotoxicity) and ISO 10993-12 (sample preparation for biological evaluation). These two tests confirm that the PET or PETG material does not release cytotoxic substances in quantities relevant to indirect patient exposure and that the sample preparation protocol used for any subsequent tests is validated. Total test cost for Korean ISBM Class II IVD reagent bottle: KRW 4\u20138M at a Korean testing laboratory (Korea Testing and Research Institute \u2014 KTR, or Korea Conformity Laboratories \u2014 KCL).<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">For Korean Class III medical device containers (direct contact with patient skin or mucous membrane): the full ISO 10993 evaluation may include cytotoxicity (ISO 10993-5), sensitisation (ISO 10993-10), irritation (ISO 10993-23), acute systemic toxicity (ISO 10993-11), and sub-chronic toxicity (ISO 10993-11 \u2014 90-day study). Total test cost: KRW 25\u201365M and 6\u20139 months calendar time. Korean ISBM packaging producers supplying Class III device manufacturers should plan for this evaluation at mould qualification \u2014 not at contract award, when the customer has already committed to the packaging specification.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korean ISBM biocompatibility evaluation documentation requirement: each ISO 10993 test report must identify the specific resin grade (manufacturer, grade designation, lot number), the ISBM process conditions used to produce the test samples (conditioning temperature, blow pressure, cycle time \u2014 because process conditions affect extractables levels), and the test laboratory&#8217;s KFDA recognition status. A biocompatibility test conducted on samples produced under different process conditions from production samples is not valid for Korean KFDA Class III \ud5c8\uac00 submission \u2014 a technical detail that catches Korean ISBM producers who use laboratory samples produced at non-standard conditions for the biocompatibility test and then change process conditions during commercial production qualification.<\/p>\n<\/section>\n<p><!-- S5 --><\/p>\n<section id=\"s5\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">5. Sterilisation Method Compatibility: Korean ISBM Bottle Options and Constraints<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 20px;\">Korean medical device containers are sterilised either at the packaging manufacturer (less common for ISBM bottles) or at the Korean medical device company&#8217;s filling facility (more common). Korean ISBM packaging producers must understand the sterilisation method the Korean medical device customer will use \u2014 because material compatibility, dimensional stability, and optical property retention under the sterilisation conditions vary significantly and determine which Korean ISBM material is technically acceptable.<\/p>\n<div style=\"overflow-x: auto; margin: 0 0 20px;\">\n<table style=\"width: 100%; border-collapse: collapse; font-size: 13.5px; min-width: 520px;\">\n<thead>\n<tr style=\"background: #075985;\">\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">Sterilisation Method<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: center; font-weight: bold;\">\uc560\uc644 \ub3d9\ubb3c<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: center; font-weight: bold;\">\ud3ab\ud2f0\uadf8<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: center; font-weight: bold;\">PP<\/th>\n<th style=\"color: #fff; padding: 9px 12px; text-align: left; font-weight: bold;\">Korean ISBM Notes<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">EO (Ethylene Oxide)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">EO process \u2264 55\u00b0C \u2014 safe for all three. Requires 24\u201348h EO residual degassing before shipping. Validate EO residual per ISO 10993-7 (\u2264 10 \u03bcg\/g EO in device).<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Gamma Irradiation<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 \u2264 25 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #f59e0b; font-weight: bold;\">\u26a0 \u2264 15 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 \u2264 50 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">PET yellows progressively above 25 kGy \u2014 specify radiation-stabilised PET grade (e.g. Eastman EB062) if dose above 20 kGy. PETG shows yellowing above 15 kGy and is generally unsuitable for standard 25 kGy gamma cycles.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">E-Beam<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 \u2264 25 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #f59e0b; font-weight: bold;\">\u26a0 \u2264 15 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 \u2264 50 kGy<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">Similar to gamma \u2014 E-beam penetrates less deeply than gamma, relevant for multi-layer stacked packaging. Single bottle: equivalent to gamma effects.<\/td>\n<\/tr>\n<tr style=\"background: #f0f9ff;\">\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; font-weight: 600;\">Steam Autoclave (121\u00b0C)<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #dc2626; font-weight: bold;\">\u2717 Not compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #dc2626; font-weight: bold;\">\u2717 Not compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Compatible<\/td>\n<td style=\"padding: 9px 12px; border-bottom: 1px solid #bae6fd;\">PET Tg ~75\u00b0C and PETG Tg ~81\u00b0C \u2014 both soften severely at 121\u00b0C. PP only ISBM material for autoclave applications. PP ISBM requires heated mould base inserts \u2014 confirm with machine supplier before specification.<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 9px 12px; font-weight: 600;\">UV-C (254nm)<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Surface only<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Surface only<\/td>\n<td style=\"padding: 9px 12px; text-align: center; color: #16a34a; font-weight: bold;\">\u2713 Surface only<\/td>\n<td style=\"padding: 9px 12px;\">Surface decontamination only \u2014 not validated sterilisation for Korean Class III\/IV containers. Used for Korean Class I\/II low-risk surface disinfection. PET absorbs UV efficiently \u2014 confirm internal surface dosage calculation for thick-wall bottles.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<p style=\"font-size: 16px; margin-bottom: 0;\">Korean ISBM producers should request the sterilisation method and validation dose from the Korean medical device customer at the quotation stage \u2014 before committing to material specification. A Korean Class II IVD container quoted as crystal-clear PETG for a customer who sterilises by 25 kGy gamma creates a material incompatibility problem that emerges at sterilisation validation, typically 6\u20138 months after mould manufacture, when the yellowed PETG bottles fail the customer&#8217;s post-irradiation clarity specification.<\/p>\n<\/section>\n<p><!-- S6 --><\/p>\n<section id=\"s6\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">6. Extractables and Leachables: Korean KFDA Expectations for ISBM Medical Containers<\/h2>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Extractables and leachables (E&amp;L) analysis is the most technically demanding documentation requirement for Korean ISBM Class III medical device containers. Extractables are chemical substances that can be liberated from the packaging material under aggressive experimental conditions (elevated temperature, solvent extraction) \u2014 they represent the maximum possible chemical exposure from the packaging material. Leachables are the subset of extractables that actually migrate into the product under normal or stressed storage conditions \u2014 they represent the actual patient or user exposure from the packaged product.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean KFDA E&amp;L expectations for primary container ISBM packaging in Korean Class III medical device \ud5c8\uac00 dossiers align with the ISO 10993-18:2020 framework (chemical characterisation of materials) and the PQRI (Product Quality Research Institute) 2006 guideline on leachables and extractables (the industry reference standard that Korean KFDA cites in its medical device submission guidance). The key analytical thresholds Korean ISBM producers must understand:<\/p>\n<ul style=\"margin: 0 0 20px; padding-left: 20px; display: flex; flex-direction: column; gap: 8px;\">\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>Analytical Evaluation Threshold (AET) for Korean Class III IVD:<\/strong> 0.1 \u03bcg\/day of any compound that cannot be identified \u2014 any extractable compound above this concentration in a simulated use extraction must be analytically identified and safety-assessed by a toxicologist. For Korean IVD reagent bottles (indirect patient contact), the AET is typically calculated on the basis of the maximum daily patient dose of the reagent, not direct consumption \u2014 allowing higher AET values than for oral drug container E&amp;L.<\/li>\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>PET-specific Korean extractables profile:<\/strong> PET primary extractables are well-characterised: acetaldehyde (AA, thermal degradation product), oligomers (cyclic PET trimer and dimer, process-temperature-dependent), and bis(2-ethylhexyl) phthalate (DEHP \u2014 if the PET resin uses DEHP-containing lubricants, which Korean pharmaceutical-grade PET resins do not). Korean medical device applications must specify PET resin from the Korean KFDA-approved food contact positive list and verify with the resin supplier that no phthalate-containing process aids are used.<\/li>\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>Process condition impact on Korean ISBM extractables:<\/strong> Higher barrel temperatures increase PET thermal degradation and AA generation; longer conditioning dwell times increase AA migration from the preform interior to the bottle wall surface. Korean ISBM producers must document the production process conditions used for E&amp;L test sample production and implement change controls preventing future process changes above the validated range \u2014 a KFDA Class III requirement that the digital process logging of the <a style=\"color: #0369a1; font-weight: 600; text-decoration: none;\" href=\"https:\/\/isbm-blow-molding.com\/ko\/isbm-industry-4-automation-korean-production-guide\/\">Korean ISBM Industry 4.0 framework<\/a> provides as an automated capability.<\/li>\n<\/ul>\n<\/section>\n<p><!-- S7 --><\/p>\n<section id=\"s7\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">7. Cleanroom Production Standards for Korean ISBM Medical Device Packaging<\/h2>\n<figure style=\"margin: 0 0 22px;\"><img decoding=\"async\" style=\"width: 100%; height: auto; border-radius: 8px; display: block;\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/injection-stretch-blow-moulding-application-1.webp\" alt=\"Korean ISBM medical device cleanroom production environment \u2014 ISO Class 8 (100,000 particles\/m\u00b3) cleanroom ISBM production for KFDA Class II IVD reagent bottles, showing filtered laminar flow HVAC, operator cleanroom garments, positive pressure room, and in-line particle monitoring for Korean medical device packaging GMP compliance\" \/><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\">Korean ISBM medical device cleanroom production \u2014 ISO Class 8 (ISO 14644-1, \u2264 3,520,000 particles\/m\u00b3 \u2265 0.5\u03bcm) is the standard production environment for Korean Class II IVD reagent bottles and Class III medical device contact containers. The ISBM process itself \u2014 one-step injection and blowing in a closed machine \u2014 is inherently cleaner than two-stage SBM (which transfers preforms through open ambient air). Korean ISBM&#8217;s closed processing is a compliance advantage: the bottle interior is formed in the blow cavity without ambient exposure until ejection, meaning the controlled ejection environment determines the final interior contamination risk.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">Korean KFDA GMP (\uc758\ub8cc\uae30\uae30\uc758 \uc81c\uc870 \ubc0f \ud488\uc9c8\uad00\ub9ac \uae30\uc900) requires medical device manufacturers to establish and maintain clean production environments appropriate to the risk level of the device being manufactured. For Korean primary container ISBM production, the relevant standard is ISO 14644-1 (Cleanrooms and associated controlled environments). Korean ISBM medical device packaging production environment requirements by device class:<\/p>\n<ul style=\"margin: 0 0 20px; padding-left: 20px; display: flex; flex-direction: column; gap: 9px;\">\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>Korean Class I (\uc2e0\uace0):<\/strong> No formal cleanroom standard required \u2014 a general industrial production environment with documented HVAC filtration (MERV 8 or equivalent, replacing standard open factory air intake) and basic housekeeping procedures. Airborne particle monitoring quarterly recommended but not mandatory.<\/li>\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>Korean Class II (\uc778\uc99d) \u2014 IVD reagent containers:<\/strong> ISO 14644-1 Class 8 production environment (\u2264 3,520,000 particles\/m\u00b3 at \u2265 0.5\u03bcm, equivalent to the old US Federal Standard 209E Class 100,000). Practical implementation: HEPA-filtered air supply to the production area, positive pressure differential (\u2265 +15 Pa) relative to adjacent non-production areas, gowning requirements (hair covers, dust coats, boot covers), and quarterly airborne particle count monitoring per ISO 14644-2.<\/li>\n<li style=\"font-size: 15px; color: #374151; line-height: 1.65;\"><strong>Korean Class III (\ud5c8\uac00) \u2014 direct contact device containers:<\/strong> ISO 14644-1 Class 7 production environment (\u2264 352,000 particles\/m\u00b3 at \u2265 0.5\u03bcm, equivalent to Class 10,000) for the ISBM machine and bottle ejection zone. Full cleanroom garments (full overalls, gloves, face masks), pass-through material entry with UV decontamination, continuous particle monitoring (real-time alarm at Class 7 limit exceedance), and annual cleanroom performance certification. Korean ISBM operations achieving Class 7 at ISBM ejection zone typically use a local laminar flow hood directly above the bottle ejection conveyor \u2014 more economical than building a full Class 7 room around the entire ISBM machine.<\/li>\n<\/ul>\n<\/section>\n<p><!-- S8 --><\/p>\n<section id=\"s8\" style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #e5e7eb;\">\n<h2 style=\"font-size: clamp(18px,2.6vw,24px); font-weight: 800; color: #075985; margin: 0 0 18px;\">8. GMP Validation: IQ, OQ, and PQ for Korean ISBM Medical Device Lines<\/h2>\n<figure style=\"margin: 0 0 22px;\"><figcaption style=\"font-size: 12px; color: #6b7280; margin-top: 8px; text-align: center;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-209\" src=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/factory-4.webp\" alt=\"\uacf5\uc7a5-4\" width=\"1536\" height=\"1024\" srcset=\"https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/factory-4.webp 1536w, https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/factory-4-1280x853.webp 1280w, https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/factory-4-980x653.webp 980w, https:\/\/isbm-blow-molding.com\/wp-content\/uploads\/2026\/02\/factory-4-480x320.webp 480w\" sizes=\"auto, (min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) and (max-width: 980px) 980px, (min-width: 981px) and (max-width: 1280px) 1280px, (min-width: 1281px) 1536px, 100vw\" \/><br \/>\nKorean ISBM GMP validation protocol \u2014 IQ (Installation Qualification) confirms the machine is installed to specification; OQ (Operational Qualification) determines the validated process parameter ranges; PQ (Performance Qualification) demonstrates consistent production at nominal conditions meeting all quality specifications. The Korean KFDA \ud5c8\uac00 submission requires all three validation phases to be completed and documented before commercial production begins \u2014 a timeline that Korean ISBM producers must plan for at contract negotiation stage, typically 4\u20136 months from mould manufacture to PQ completion.<\/figcaption><\/figure>\n<p style=\"font-size: 16px; margin-bottom: 14px;\">GMP IQ\/OQ\/PQ validation is the core of Korean Class III medical device container ISBM qualification. Each phase serves a distinct purpose and generates specific documentation for the KFDA \ud5c8\uac00 dossier.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><strong>IQ (Installation Qualification):<\/strong> Confirms that the Korean ISBM machine, mould, and ancillary equipment (dryer, chiller, compressed air system) are installed in accordance with manufacturer specifications. IQ documentation for Korean KFDA Class III includes: machine serial number and model confirmation, calibration certificates for all measuring instruments (thermocouples, pressure transducers, weight scales) with KRISS traceability, utility verification (cooling water temperature, flow rate, blow air pressure, dewpoint at machine inlet), and cleanroom environmental measurement at installation (particle count, temperature, humidity, differential pressure). Korean Ever-Power provides machine-specific IQ documentation templates covering all required data fields for Korean KFDA medical device IQ protocol completion.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 14px;\"><strong>OQ (Operational Qualification):<\/strong> Determines the validated operating ranges for each critical process parameter by challenging the process at parameter extremes and confirming acceptable product at each level. Typical Korean ISBM OQ study: 3 levels of each critical parameter (nominal \u2212 5%, nominal, nominal + 5%) for conditioning temperature, blow dwell time, and injection fill pressure; 30-bottle samples at each parameter level; dimensional and quality measurements (weight, neck OD, haze, wall thickness at 5 positions, visual inspection) at each level. OQ acceptance criteria: all quality attributes within specification at all parameter levels \u2014 establishing the validated parameter ranges within which production must operate. Parameters that produce failing product at nominal \u00b1 5% require the nominal setpoint to be re-optimised and the OQ repeated \u2014 a common OQ finding for Korean ISBM Class III producers who have not previously produced to Class III precision tolerances.<\/p>\n<p style=\"font-size: 16px; margin-bottom: 0;\"><strong>PQ (Performance Qualification):<\/strong> Demonstrates that the Korean ISBM process produces consistent specification-compliant product at nominal conditions over a minimum of 3 consecutive production runs at commercial scale. PQ sampling plan: minimum 125 bottles per cavity per run (total 375 per cavity for 3 runs), measured at 9 quality attributes including dimensional measurements, weight, haze, visual inspection per AQL Level II (ANSI\/ASQ Z1.4 \/ ISO 2859-1), and biocompatibility sample production confirmation. PQ statistical analysis: process capability (Cpk) \u2265 1.33 for each critical quality attribute \u2014 the Korean KFDA Class III standard for validated manufacturing capability. EV servo ISBM Korean platforms consistently achieve Cpk \u2265 1.50 for bottle weight and neck OD at nominal conditions; hydraulic Korean platforms typically achieve Cpk 1.00\u20131.20, which is below the Korean Class III standard and necessitates the hydraulic-to-EV-servo upgrade that Korean ISBM producers entering Class III supply consistently encounter as a prerequisite for successful PQ completion.<\/p>\n<\/section>\n<p><!-- FAQ --><\/p>\n<section style=\"margin: 56px 0 0; padding: 36px 0 0; border-top: 2px solid #075985;\">\n<h2 id=\"faq\" style=\"font-size: clamp(19px,2.8vw,25px); font-weight: 800; color: #075985; margin: 0 0 24px;\">\uc790\uc8fc \ubb3b\ub294 \uc9c8\ubb38<\/h2>\n<div style=\"display: flex; flex-direction: column; gap: 2px;\">\n<div style=\"border: 1px solid #bae6fd; border-radius: 8px 8px 0 0; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q1 \u2014 What is the minimum Korean ISBM investment for entering Korean Class II IVD medical device packaging supply?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">The minimum investment for a Korean ISBM producer to qualify as a Korean Class II IVD reagent container supplier to a Korean notified body (\uc778\uc99d\uae30\uad00) certified medical device manufacturer comprises four components. (1) Quality system upgrade to ISO 13485:2016: Korean ISBM producers already operating under ISO 9001:2015 can achieve ISO 13485 upgrade in 6\u20139 months for KRW 8\u201315M (gap analysis, documentation revision, audit, certification) with a Korean accredited certification body. ISO 13485 is the Korean medical device quality management standard referenced in KFDA \uc778\uc99d process requirements. (2) ISO 10993-5 cytotoxicity test on production samples: KRW 1.5\u20133M at KTR or KCL; produces the biocompatibility certificate the Korean notified body requires. (3) Production environment upgrade to ISO 14644-1 Class 8: for a Korean ISBM production area of 80\u2013120 m\u00b2, HEPA filtration retrofit and positive pressure management: KRW 15\u201330M including validation. (4) GMP documentation system: batch records, equipment calibration programme, supplier qualification for resin and masterbatch, annual management review. If implemented from scratch: KRW 5\u201310M for documentation development and staff training. Total minimum investment: KRW 30\u201358M over 12\u201318 months. The corresponding commercial benefit: Korean Class II IVD medical device container pricing is typically KRW 45\u2013120\/bottle \u2014 2\u20134\u00d7 the margin per bottle of equivalent Korean commodity packaging \u2014 and Korean medical device manufacturer contracts are typically 3\u20135 year supply agreements, providing revenue stability unavailable in Korean commodity packaging markets.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q2 \u2014 How does Korean ISBM one-step processing differ from two-stage SBM for Korean medical device compliance purposes?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Korean ISBM one-step processing has two compliance advantages over two-stage SBM (stretch blow moulding from pre-manufactured preforms) for Korean medical device applications. First, fewer process steps requiring individual validation: two-stage SBM requires separate GMP validation of preform injection moulding (IQ\/OQ\/PQ for the injection moulding machine) plus separate GMP validation of the reheat SBM process \u2014 two separate validation exercises, two sets of equipment calibration, two production environments to qualify under ISO 14644. Korean one-step ISBM combines both steps in a single validated process with one IQ\/OQ\/PQ protocol, approximately halving the validation effort. Second, no preform inventory and handling compliance requirement: two-stage SBM creates an intermediate preform inventory that must be stored in a qualified environment, tracked by lot number, and controlled for storage time limits (PET preforms degrade in crystallinity if stored too long before blowing). Korean one-step ISBM eliminates the preform storage compliance requirement entirely \u2014 the preform is made and immediately blown in the same cycle, with no intermediate product requiring environmental controls, lot traceability, or shelf-life management. For Korean pharmaceutical ISBM, this advantage is well-recognised. For Korean medical device ISBM, it is equally relevant \u2014 Korean Class III \ud5c8\uac00 submission documentation is simplified by one-step processing because the number of critical process steps requiring individual validation is reduced, shortening the IQ\/OQ\/PQ timeline by 2\u20134 months compared to a two-stage production process qualification.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q3 \u2014 Does gamma irradiation change the extractables profile of Korean ISBM PET medical device bottles?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Yes \u2014 gamma irradiation generates free radicals in PET that produce a distinct set of radiation-induced degradation products in addition to the thermal degradation products present before irradiation. The primary radiation-induced extractables from Korean ISBM PET at 25 kGy are: (1) Increased acetaldehyde (gamma irradiation breaks additional ester bonds in the PET chain, releasing additional AA above the thermal AA from the ISBM process); (2) Vinyl alcohol oligomers (gamma scission of terminal vinyl groups); (3) Elevated PET cyclic oligomers (radiation promotes additional oligomer formation from chain scission). For Korean KFDA Class III medical device containers that are gamma-sterilised, the E&amp;L study must be conducted on irradiated samples \u2014 not on unirradiated production samples \u2014 because the radiation-induced extractables are part of the container&#8217;s actual chemical profile that patients are exposed to. Korean ISBM producers who conduct their E&amp;L study on unirradiated bottles and then sterilise by gamma have a deficiency in their Korean KFDA \ud5c8\uac00 dossier that becomes apparent only at KFDA review, requiring a repeat E&amp;L study on irradiated samples and delaying the \ud5c8\uac00 approval by 3\u20136 months. Specify in the E&amp;L test protocol from the outset that samples must be irradiated at the maximum intended dose before extraction \u2014 saving the repeat study cost and approval delay.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q4 \u2014 How does acetaldehyde in Korean ISBM PET affect medical device reagent quality?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Acetaldehyde (AA) migration from Korean ISBM PET bottles into medical device reagents is a relevant quality concern for specific Korean IVD reagent categories \u2014 particularly enzyme-based diagnostic reagents where AA can react with enzyme active sites, and immunoassay reagents where AA can react with antibody proteins through Maillard reactions, reducing assay sensitivity. The AA migration threshold that causes measurable Korean IVD reagent performance degradation depends on the specific reagent matrix \u2014 enzyme-based IVD reagents show performance degradation at AA concentrations above 15 ppb in the stored reagent; immunoassay reagents are typically unaffected at Korean ISBM PET AA levels (1\u20138 ppb headspace AA in a 100ml PET bottle at ambient temperature, 3 months storage). Korean ISBM producers supplying Korean IVD diagnostic companies must disclose the measured headspace AA in bottles produced at commercial conditions (conditioning temperature, barrel temperature, cycle time) to the Korean medical device customer&#8217;s formulation team \u2014 and commit to maintaining AA below the agreed limit in all commercial production through process parameter controls and annual verification testing. The main ISBM parameter levers for reducing AA in Korean medical device PET bottles are: minimise barrel temperature (target 265\u00b0C zone 1, not 280\u00b0C+), minimise barrel residence time (do not leave PET in the barrel at temperature during stoppages above 10 minutes), and minimise conditioning dwell time (minimum adequate for quality, not maximum).<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-top: none; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q5 \u2014 What Korean ISBM change control requirements apply after achieving Korean Class III KFDA \ud5c8\uac00?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Korean KFDA \ud5c8\uac00-approved medical device packaging is subject to change control requirements that bind the Korean ISBM packaging manufacturer once the container specification is included in the Korean device manufacturer&#8217;s \ud5c8\uac00 dossier. Changes to the ISBM container that require Korean KFDA change notification (\ubcc0\uacbd\ud5c8\uac00 or \ubcc0\uacbd\uc2e0\uace0 depending on significance) and potentially a Korean KFDA review and re-approval include: changes to resin grade or manufacturer; changes to colorant or masterbatch specification; changes to the ISBM machine (model, serial number, location); significant process parameter changes outside the validated range established in OQ; and dimensional specification changes above the approved tolerance in the \ud5c8\uac00 dossier. Changes that typically do not require KFDA change notification (but do require internal change control documentation): within-range process parameter adjustments, ISBM operator certification changes, production environment improvements that maintain or exceed the validated cleanroom class. Korean ISBM packaging producers who treat their validated medical device container process as mutable \u2014 adjusting barrel temperatures without change control, substituting resin grades without supplier qualification, or moving ISBM machines between facilities without KFDA notification \u2014 create Korean KFDA compliance deficiencies that emerge at the device manufacturer&#8217;s next KFDA inspection, triggering corrective action requirements against the packaging supplier. The practical implication: ISBM producers entering Korean Class III medical device supply should dedicate a specific machine, mould, and resin supply chain to the medical device contract, with a change control system that prevents any change without formal review and, where required, Korean KFDA notification.<\/p>\n<\/div>\n<\/div>\n<div style=\"border: 1px solid #bae6fd; border-radius: 0 0 8px 8px; overflow: hidden;\">\n<div style=\"background: #f0f9ff; padding: 14px 20px; border-bottom: 1px solid #bae6fd;\">\n<p style=\"font-size: 15px; font-weight: bold; color: #075985; margin: 0;\">Q6 \u2014 How does Korean ISBM dimensional precision compare to glass for Korean medical device container neck OD compliance?<\/p>\n<\/div>\n<div style=\"padding: 16px 20px;\">\n<p style=\"font-size: 15px; color: #374151; margin: 0; line-height: 1.7;\">Korean ISBM PET and PETG bottles achieve neck OD dimensional precision of \u00b10.04mm (4-sigma, EV servo platform) at 4-cavity production \u2014 equivalent to or superior to pharmaceutical-grade glass bottle neck OD precision (typically \u00b10.05\u20130.10mm depending on glass moulding process and neck size). For Korean medical device applications where the closure (snap-cap, luer connector, septum) depends on neck OD tolerance for leak-free sealing, Korean ISBM&#8217;s \u00b10.04mm precision provides more consistent closure performance than glass&#8217;s \u00b10.05\u20130.10mm, with the additional advantage of being quantifiably verified per cavity in production (glass manufacturers provide dimensional certification at statistical sample level, not per-cavity). Two Korean medical device container requirements where glass retains an advantage over Korean ISBM PET\/PETG: (1) UV barrier for highly photosensitive reagents \u2014 amber glass blocks \u226599.9% of UV below 450nm; amber PET or amber PETG blocks 95\u201399% but requires validated masterbatch and migration testing; (2) Water vapour transmission rate (WVTR) \u2014 glass has zero WVTR; PET WVTR is approximately 1.5\u20133.0 g\u00b7mm\/m\u00b2\u00b7day at 38\u00b0C\/90% RH \u2014 acceptable for most aqueous IVD reagents at standard Korean laboratory storage (15\u201330\u00b0C) but requires humidity barrier closure for reagents sensitive to dilution from atmospheric moisture absorption over 18+ month shelf life.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n<p><!-- CTA --><\/p>\n<div style=\"background: linear-gradient(135deg,#020c1a 0%,#0369a1 100%); border-radius: 10px; padding: clamp(30px,5vw,50px) clamp(20px,4vw,40px); text-align: center; margin: 56px 0 48px;\">\n<p style=\"font-size: 10px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #7dd3fc; margin: 0 0 12px;\">Medical Device Qualification Support<\/p>\n<h2 style=\"font-size: clamp(18px,3vw,26px); font-weight: 800; color: #fff; margin: 0 0 14px;\">Entering Korean KFDA Class II or Class III Medical Device Packaging? Need GMP Validation, ISO 10993, or IQ\/OQ\/PQ Support?<\/h2>\n<p style=\"font-size: 15px; color: #e0f2fe; max-width: 480px; margin: 0 auto 26px; line-height: 1.65;\">Korean Ever-Power provides KFDA Class II\/III documentation templates, GMP IQ\/OQ\/PQ protocol development, biocompatibility sample production, EV servo process logging for KFDA Annex 11 compliance, and cleanroom ISBM commissioning for Korean medical device packaging qualification.<\/p>\n<p><a style=\"display: inline-block; background: #f97316; color: #fff; padding: 14px 36px; border-radius: 6px; text-decoration: none; font-weight: bold; font-size: 15px;\" href=\"https:\/\/isbm-blow-molding.com\/ko\/contact-us\/\">Request Medical Device Qualification Support<\/a><\/p>\n<\/div>\n<p><!-- RELATED RESOURCES --><\/p>\n<section style=\"margin-bottom: 56px;\">\n<p style=\"font-size: 10.5px; font-weight: bold; letter-spacing: 2px; text-transform: uppercase; color: #075985; margin-bottom: 16px;\">\uad00\ub828 \uc790\ub8cc<\/p>\n<div style=\"display: flex; flex-wrap: wrap; gap: 16px;\">\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #075985; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Premium Medical Grade<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">Injection Stretch Blow Moulding Machine HGY150-V4-EV<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">All-electric EV servo \u00b7 KFDA Annex 11 GMP data logging \u00b7 Cpk \u2265 1.50 for Class III PQ requirement \u00b7 Korean medical device IQ\/OQ\/PQ documentation package available.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #075985; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">Class II IVD Platform<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">\uc0ac\ucd9c \uc5f0\uc2e0 \ube14\ub85c\uc6b0 \uc131\ud615\uae30 HGY200-V4<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">Multi-resin PET \/ PETG \/ PP \u00b7 \u00b10.04mm neck OD precision \u00b7 Korean Class II ISO 13485 compatible \u00b7 Radiation-stabilised PET grade validated \u00b7 IVD reagent bottle 15\u2013500ml.<\/span><\/div>\n<p>&nbsp;<\/p>\n<div style=\"background: #fff; border: 1.5px solid #bae6fd; border-top: 4px solid #075985; border-radius: 8px; padding: 18px 20px;\"><span style=\"display: block; font-size: 9px; font-weight: bold; color: #f97316; letter-spacing: 1.5px; text-transform: uppercase; margin-bottom: 8px;\">High-Volume Medical<\/span><br \/>\n<span style=\"display: block; font-size: 15px; font-weight: bold; color: #1e3a8a; margin-bottom: 8px; line-height: 1.3;\">\uc0ac\ucd9c \uc5f0\uc2e0 \ube14\ub85c\uc6b0 \uc131\ud615\uae30 HGY250-V4<\/span><br \/>\n<span style=\"display: block; font-size: 13px; color: #6b7280; line-height: 1.55;\">Large IVD reagent kit bottle production \u00b7 6-cavity Korean Class II output \u00b7 Cleanroom-compatible ejection system \u00b7 Wide-mouth 86mm neck for large diagnostic reagent containers.<\/span><\/div>\n<p>&nbsp;<\/p>\n<\/div>\n<\/section>\n<p>&nbsp;<\/p>\n<footer style=\"text-align: center; padding: 32px 0 24px; border-top: 1px solid #e5e7eb;\">\n<p style=\"font-size: 12px; color: #9ca3af; margin: 0;\">\ud3b8\uc9d1\uc790: Cxm<\/p>\n<\/footer>\n<\/div>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>Application of ISBM \u00b7 Medical Device Packaging \u00b7 Korean ISBM 2026 ISBM Medical Device Bottle Production: Korean Regulatory Guide Korean medical device packaging is the highest-compliance ISBM application \u2014 where every bottle must be biocompatibility-tested, sterilisation-validated, dimensionally qualified to GMP IQ\/OQ\/PQ standards, and manufactured in a documented clean environment. Korean ISBM producers who enter this [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[24],"tags":[],"class_list":["post-966","post","type-post","status-publish","format-standard","hentry","category-technical-deep-dive"],"_links":{"self":[{"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/posts\/966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/comments?post=966"}],"version-history":[{"count":1,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/posts\/966\/revisions"}],"predecessor-version":[{"id":967,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/posts\/966\/revisions\/967"}],"wp:attachment":[{"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/media?parent=966"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/categories?post=966"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/isbm-blow-molding.com\/ko\/wp-json\/wp\/v2\/tags?post=966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}